Home/Filings/4/0000914190-20-000160
4//SEC Filing

WIENS HAROLD J 4

Accession 0000914190-20-000160

CIK 0000842023other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:35 PM ET

Size

15.0 KB

Accession

0000914190-20-000160

Insider Transaction Report

Form 4
Period: 2020-04-30
Transactions
  • Exercise/Conversion

    Common Stock

    2020-04-30$91.78/sh+4,000$367,1209,221 total
  • Sale

    Common Stock

    2020-04-30$225.00/sh4,000$900,0005,221 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2020-04-304,0000 total
    Exercise: $91.78From: 2014-10-30Exp: 2024-10-30Common Stock (4,000 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $87.34From: 2016-10-29Exp: 2025-10-28Common Stock (4,260 underlying)
    4,260
  • Stock Option (right to buy)

    Exercise: $125.05From: 2018-10-25Exp: 2027-10-26Common Stock (3,125 underlying)
    3,125
  • Stock Option (right to buy)

    Exercise: $101.19From: 2017-10-26Exp: 2026-10-26Common Stock (3,985 underlying)
    3,985
  • Stock Option (right to buy)

    Exercise: $179.84From: 2019-10-24Exp: 2028-10-25Common Stock (1,898 underlying)
    1,898
  • Stock Option (right to buy)

    Exercise: $201.64Exp: 2029-10-24Common Stock (2,011 underlying)
    2,011
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2019.
  • [F2]The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne's 2020 annual meeting of shareholders.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001197788

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:35 PM ET
Size
15.0 KB